• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

PACSIN2 does not influence thiopurine-related toxicity in patients with inflammatory bowel disease.

作者信息

Roberts Rebecca L, Wallace Mary C, Seinen Margien L, Krishnaprasad Krupa, Chew Angela, Lawrance Ian, Prosser Ruth, Bampton Peter, Grafton Rachel, Simms Lisa, Studd Corrie, Bell Sally J, Radford-Smith Graham, Andrews Jane M, Barclay Murray L

机构信息

1] Department of Surgical Sciences (Dunedin), VU University Medical Center, Amsterdam, The Netherlands [2] On behalf of the Australian and New Zealand Inflammatory Bowel Disease Consortium.

Department of Gastroenterology and Hepatology, VU University Medical Center, Amsterdam, The Netherlands.

出版信息

Am J Gastroenterol. 2014 Jun;109(6):925-7. doi: 10.1038/ajg.2014.89.

DOI:10.1038/ajg.2014.89
PMID:24896764
Abstract
摘要

相似文献

1
PACSIN2 does not influence thiopurine-related toxicity in patients with inflammatory bowel disease.PACSIN2不影响炎症性肠病患者的硫嘌呤相关毒性。
Am J Gastroenterol. 2014 Jun;109(6):925-7. doi: 10.1038/ajg.2014.89.
2
PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity.PACSIN2 多态性影响 TPMT 活性和巯基嘌呤相关的胃肠道毒性。
Hum Mol Genet. 2012 Nov 1;21(21):4793-804. doi: 10.1093/hmg/dds302. Epub 2012 Jul 30.
3
as a modulator of autophagy and mercaptopurine cytotoxicity: mechanisms in lymphoid and intestinal cells.作为自噬和巯基嘌呤细胞毒性的调节剂：在淋巴和肠道细胞中的机制。
Life Sci Alliance. 2023 Jan 3;6(3). doi: 10.26508/lsa.202201610. Print 2023 Mar.
4
Biomarkers for gastrointestinal adverse events related to thiopurine therapy.与硫嘌呤治疗相关的胃肠道不良事件的生物标志物。
World J Gastroenterol. 2021 Oct 14;27(38):6348-6356. doi: 10.3748/wjg.v27.i38.6348.
5
The Effect of Renal Replacement Therapy in a Patient with Mercaptopurine Toxicity: Time to Revise Guidelines.巯嘌呤毒性患者中肾脏替代治疗的效果：是时候修订指南了。
Curr Drug Saf. 2024;19(2):299-302. doi: 10.2174/1574886318666230714105801.
6
Early prediction of thiopurine-induced hepatotoxicity in inflammatory bowel disease.炎症性肠病中硫嘌呤诱导的肝毒性的早期预测
Aliment Pharmacol Ther. 2017 Feb;45(3):391-402. doi: 10.1111/apt.13879. Epub 2016 Dec 12.
7
Association between thiopurine S-methyltransferase polymorphisms and thiopurine-induced adverse drug reactions in patients with inflammatory bowel disease: a meta-analysis.硫嘌呤 S-甲基转移酶基因多态性与炎症性肠病患者硫嘌呤类药物所致药物不良反应的关联：一项荟萃分析。
PLoS One. 2015 Mar 23;10(3):e0121745. doi: 10.1371/journal.pone.0121745. eCollection 2015.
8
[Optimized thiopurine treatment in chronic inflammatory bowel disease].[慢性炎症性肠病的优化硫嘌呤治疗]
Ugeskr Laeger. 2014 May 26;176(22).
9
Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease.鉴定 TPMT 变异患者并减少巯嘌呤剂量可降低炎症性肠病患者在硫唑嘌呤治疗期间的血液学事件。
Gastroenterology. 2015 Oct;149(4):907-17.e7. doi: 10.1053/j.gastro.2015.06.002. Epub 2015 Jun 11.
10
More Dose-dependent Side Effects with Mercaptopurine over Azathioprine in IBD Treatment Due to Relatively Higher Dosing.由于相对较高的剂量，巯嘌呤在治疗 IBD 时比硫唑嘌呤有更多的剂量依赖性副作用。
Inflamm Bowel Dis. 2017 Oct;23(10):1873-1881. doi: 10.1097/MIB.0000000000001163.

引用本文的文献

1
PACSIN proteins in vivo: Roles in development and physiology.体内的 PACSIN 蛋白：在发育和生理中的作用。
Acta Physiol (Oxf). 2022 Mar;234(3):e13783. doi: 10.1111/apha.13783. Epub 2022 Jan 20.
2
Pharmacogenomic and Pharmacotranscriptomic Profiling of Childhood Acute Lymphoblastic Leukemia: Paving the Way to Personalized Treatment.儿童急性淋巴细胞白血病的药物基因组学和药物转录组学分析：为个体化治疗铺平道路。
Genes (Basel). 2019 Mar 1;10(3):191. doi: 10.3390/genes10030191.
3
The Promise of Pharmacogenomics in Reducing Toxicity During Acute Lymphoblastic Leukemia Maintenance Treatment.
药物基因组学在降低急性淋巴细胞白血病维持治疗期间毒性方面的前景。
Genomics Proteomics Bioinformatics. 2017 Apr;15(2):82-93. doi: 10.1016/j.gpb.2016.11.003. Epub 2017 Apr 6.
4
Polymorphic variation in TPMT is the principal determinant of TPMT phenotype: A meta-analysis of three genome-wide association studies.TPMT基因的多态性变异是TPMT表型的主要决定因素：三项全基因组关联研究的荟萃分析。
Clin Pharmacol Ther. 2017 May;101(5):684-695. doi: 10.1002/cpt.540. Epub 2017 Feb 1.
5
NUDT15 R139C causes thiopurine-induced early severe hair loss and leukopenia in Japanese patients with IBD.NUDT15 R139C在日本炎症性肠病患者中导致硫嘌呤诱导的早期严重脱发和白细胞减少。
Pharmacogenomics J. 2016 Jun;16(3):280-5. doi: 10.1038/tpj.2015.43. Epub 2015 Jun 16.